Euronext: two new French-American guests
Paris – Two US companies with French roots have listed on the Euronext without raising money. Cardiovascular, neurology and metabolic company Quantum Genomics Corp. registered 39.3 million shares for trading at EUR1.04. The second firm new to the stock exchange is BioQuanta Corp., a cancer, cardiovascular and infectious diseases discovery service company with headquarters in the US but research operations in France. The firm listed 2.5 million shares at EUR4.17. Quantum CEO Lionel Segerd said the US-run French company has decided it prefers to raise money when the financial climate has improved.